Poultry Vaccine Market: By Vaccine (Inactivated Vaccines, Live Attenuated Vaccines, and Others), By Application (Marek’s Disease, Newcastle Disease, Infectious Bursal Disease, Infectious Bronchitis, Avian Influenza, Coccidiosis, Mycoplasma, and Others), and Geography  

The poultry vaccine market is anticipated to be valued at USD 2199.8 million in 2021 and is expanded to grow at a significant CAGR of 5.8% over 2022-2028. The disease outbreaks in poultry drive the poultry vaccine market. Growing farmed poultry can speed up the spread of infectious pathogens among birds, such as the avian influenza virus, which has the great promise to cause widespread mortality and significant economic losses in poultry. However, poultry is accepted as a good source of protein. The poultry industry will be forced to intensify production in many countries, leading to more significant numbers of farms that house birds at elevated densities. Hence the regulatory bodies are accelerating the approval process for various vaccines related to veterinary health. Increasing awareness among veterinary practitioners about animal vaccination, growing meat consumption, and rising government initiatives for food safety is boosting the market. For instance, in April 2019, according to the Middle East Rating Agency, the Qatar government established central food laboratories with different procedures and analyses on food safety to ensure consumers are provided with contamination-free, safe, and high-quality meat products. The growing poultry population, combined with the rising prevalence of avian diseases, will also drive market growth in the coming years. Moreover, infected meat consumption risks human health, thereby making it imperative that the birds be vaccinated before usage. The main obstacles poultry farms face are the rapid spread of diseases and the lack of treatment options. To prevent such situations, vaccination becomes mandatory. In 2021, the attenuated live vaccines segment held the largest revenue share. Live attenuated vaccines' duration of immunity lasts longer and protects against avian diseases such as infectious bronchitis, infectious bursal disease, and Newcastle disease. Moreover, growing R&D activities, particularly in this field of vaccination, to curb various outbreaks of the diseases mentioned above are accentuating the segment growth.

Recent Market Developments:

In February 2021, Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA announced the completion of its acquisition of PrognostiX Poultry Limited d/b/a Poultry Sense Ltd. from its founding shareholders. In July 2020, Boehringer Ingelheim acquires GST to strengthen its stem cell capabilities in Animal Health.